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Abstract
Background: The familial clustering of multinodular goitres (MNGs) with a dominant mode of inheritance has been
repeatedly reported. Linkage studies have revealed several genetic loci responsible for familial MNG; however, most of the
causative variants remain unknown.
Methods and Results: Through linkage analysis using single-nucleotide polymorphism markers, we identified a new MNG
locus on 19p13.2-q12 in a five-generation Japanese MNG family. Subsequent mutation searches focusing on the candidate
25-Mb region of chromosome 19 identified a heterozygous mutation, c.879_880delinsA, p.Asp294Thr, fs*23, in exon 3 of the
KEAP1, which plays a central role in the cytoprotection pathway against oxidative stress. Reverse transcriptase-PCR analysis
showed low expression of wild type KEAP1 accompanied by no transcription product of mutant allele in the normal and
goitre region of thyroid tissues obtained from the proband. In agreement with previous studies showing that KEAP1
negatively regulates NFE2L2, the NFE2L2 target genes GSTA4 and GCLC were up-regulated in the thyroid tissues of the
patient.
Conclusions: This study identified the first KEAP1 mutation in MNG. The results provide insights into the pathogenesis of
goitre which develops in the organ continuously exposed to oxidative stress during hormone synthesis.
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Introduction
A nontoxic multinodular goitre (MNG) (Online Mendelian
Inheritance in Man [OMIM] 138800) is clinically characterised by
the nodular enlargement of the thyroid gland without thyroid
dysfunction or inflammation. In general population in an area
with borderline iodine deficiency, MNG are found by ultrasonog-
raphy in approximate 23% of the population [1]. Multiple factors,
such as sex, iodine deficiency and smoking, influence the
development of MNG [2–5]. In addition, familial and twin studies
in endemic and nonendemic regions have indicated a genetic
predisposition for MNGs [2,5–7]. Because a history of MNG has
been suggested to be a risk factor for the development of toxic
goitres and thyroid cancer [8,9], it is important to identify the
genes involved in MNG for early diagnosis and for a better
understanding of the pathogenesis of thyroid disease.
Linkage analysis using familial MNG has been one of the
approaches used to identify causative genes for the disease. Several
studies have reported genetically linked loci for familial MNG.
Studies in German and Canadian pedigrees with nontoxic MNG
identified a susceptibility locus on chromosome 14q, which is
called MNG-1 (OMIM 138800) [10,11]. In 2000, Capon et al.
mapped MNG-2 (OMIN 300273) on chromosome Xp22 with
linkage analysis of a three-generation Italian pedigree [12].
Another locus, MNG-3 (OMIM 606082), was identified on
chromosome 3q26.1-q26.3 from two independent Japanese
pedigrees presenting with MNG with euthyroidism and high
thyroid-stimulating hormone levels [13]. Furthermore, four
candidate loci were reported on chromosomes 2q, 3p, 7q and
8p with linkage analysis in Danish, German and Slovakian families
[14]. Thus, linkage results indicate genetic heterogeneity in the
aetiology of MNG, even in familial cases with a Mendelian mode
of inheritance [15].
Based on observations that pleuropulmonary blastoma (PPB)
families also have MNG, Rio Frio et al. screened mutations of the
PPB-causative gene dicer 1, ribonuclease type III (DICER1), which
is located in the MNG-1 locus in MNG families, and identified
several mutations linked to MNG [16]. However, except for this
recent finding, causative genes for euthyroid MNG in other loci
have remained unclear. Considering the genetic heterogeneity of
the disease, additional linkage analyses using additional families to
validate reported loci or to detect novel loci followed by
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comprehensive sequencing analysis targeting linkage regions are
required to explain the genetic aetiology of MNG.
In the present study, we identified a novel germline mutation in
kelch-like ECH-associated protein 1 (KEAP1) in a Japanese
pedigree with MNG through a combination of genome-wide
linkage analysis using a high-density single-polymorphism nucle-
otide (SNP) array and next-generation sequencing. Subsequent
gene expression analysis showed the functional activation of
nuclear factor (erythroid-derived 2)-like 2 (NFE2L2), which is
negatively regulated by KEAP1, in the thyroid tissue of the
patient. Our study suggests that dysfunction of the KEAP1-
NFE2L2 stress-response pathway may contribute to the nodular
process in thyroid tissue, which is physiologically exposed to the
oxidative nature of thyroid hormone synthesis.
Methods
Subjects
We identified a 5-generation Japanese family presenting with a
dominant inheritance pattern of familial thyroid goitre (Figure 1
and Table S1). The proband (V:2) was a 15-year-old girl from the
western area of Japan who had been referred to our hospital.
Ultrasonographic examination showed multiple cystic lesions in
both of the thyroid lobes, and the level of thyroid hormone was
within the normal range (TSH, 0.67 mU/ml; free T3, 4.16 pg/ml;
free T4, 1.56 ng/dl). Her older sister (V:1) had a thyroid
lobectomy at 8 years old. Their pathological diagnoses were
adenomatous goitre. They do not show any sign of malignancy in
organs including the thyroid in medical follow-up after a thyroid
lobectomy. We obtained 13 blood samples from the family,
including 8 affected (III:4, III:6, III:8, IV:2, IV:4, V:1, V:2 and
V:4) and 5 unaffected (III:3, III:9, IV:1, IV:3 and V:3) individuals,
and goitre and matched normal thyroid tissue from the proband
(V:2). The age of onset was 8–50 years old. None of the affected
individual showed any evidence of malignancy. A total of 192
unrelated normal controls from a population-based Japanese
cohort were subjected to sequencing to evaluate the frequency of
the KEAP1 mutation in the general population. All participants
provided their written informed consent to participate in this study
according to the Declaration of Helsinki. We obtained written
informed consent from the parents on the behalf of the children
participants. This study was approved by the Ethics Committee at
Kyushu University, Fukuoka, Japan.
DNA isolation and SNP genotyping
Genomic DNA was extracted from peripheral blood leukocytes
using the QIAamp DNA Blood Midi Kit (Qiagen) and adjusted to
a final concentration of 50 ng/ml for SNP typing. The Illumina
Human CNV370K-Quad Array and the Illumina BeadStation
500G SNP genotyping system were employed for genome-wide
SNP typing according to the manufacturer’s protocols. SNP
genotypes were determined with the BeadStudio Genotyping
Analysis Module 3.3.7 software. All of the samples showed call
rates greater than 0.99 (the average was 0.998, Table S2), and
342,115 SNPs on chromosomes 1 to X had a call frequency of 1.0.
Based on the results of the Mendelian error check of PLINK v1.06
(http://pngu.mgh.harvard.edu/purcell/plink/) [17], 293 SNPs
were excluded, and the remaining 341,822 SNPs were available
for linkage analysis. To estimate genome-wide pairwise IBD, we
additionally excluded 94,826 SNPs that were homozygous in all of
the samples; the remaining 246,996 SNPs were subjected to the
IBD analysis. The quality control of the SNP typing is shown in
Figure S1.
Statistical analysis
The genome-wide IBD for all pairs of individuals was estimated
using PLINK v1.06 to evaluate pedigree errors. Multipoint
parametric LOD scores and the information score were calculated
using GeneHunter v2.1r5 (with easyLINKAGEPlus v5.08)
[18,19]. A total of 3,514 and 454 SNPs whose pair-wise r-square
was ,0.01 were automatically selected by easyLINKAGE for
linkage analysis to the whole genome (1.0 cM spacing) and to
chromosome 19 (0.2 cM spacing), respectively (Table S3). The
model used in the parametric analyses assumed a dominant model
of inheritance, a disease allele frequency of 0.001 and complete
penetrance. The marker genetic position was based on the
Marshfield linkage map [20], and the sex-averaged position was
applied.
Exome capture and next-generation sequencing
The genomic DNA of the proband was subjected to sequencing.
The SureSelect Human All Exon System (Agilent Technologies)
was employed to capture whole-genome exons. The Illumina
Genome Analyser GAIIx was used for sequencing, and 75 base
reads were generated.
Read mapping and variant analysis of the linkage region
Read mapping and the subsequent variant analysis of chromo-
some 19 were performed with CLC Genomic Workbench 4.6.1
(CLC bio). The following parameters were used to map reads to a
reference genome (GRCh37): similarity = 0.95, length fraction =
1.0, insertion cost = 3, deletion cost = 3 and mismatch cost = 2.
Subsequently, to discover the conflict of a mapping, SNP and DIP
(deletion/insertion polymorphisms) detections were performed
using the default setting. To select potential mutations critical for
the pathology of MNG, we eliminated the known variants that
were listed in dbSNP132 or the variants that showed synonymous
amino acid substitution. The reads that were incorrectly mapped
were identified and removed using BLAT Search Genome in the
UCSC database (http://genome.ucsc.edu/). The conflicts that
resulted in a low quality value were considered to be artefacts. A
summary of the sequencing and mapping is shown in Figure S2.
Polyphen-2, Mutation Taster and SIFT classification tools were
used to determine the amino acid changes that most likely
destroyed protein function [21–23]. The direct sequencing of
Figure 1. A pedigree of a five-generation multinodular goitre
family. Individuals are numbered above each symbol. Individuals
affected with MNG are indicated by filled symbols and age of onset is
described under the patient symbol. The arrow shows a proband of this
family study. The bars above each symbol indicate individuals included
in the linkage analysis.
doi:10.1371/journal.pone.0065141.g001
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KEAP1 was performed using the primers 5’- CTGAGC-
GACTGTCGGAAGTA-3’ and 5’-GGCCAAGCAAGAGGAG-
TTCT-3’ for PCR amplification and the primer 5’-GGCCAAG-
CAAGAGGAGTTCT-3’ (the reverse primer of PCR) for
sequencing according to a standard procedure.
Reverse transcriptase-PCR
Total RNA was extracted from frozen thyroid tissues of the
proband using an RNeasy Mini Kit (Qiagen) and was subjected to
reverse transcription with the use of a First-strand cDNA Synthesis
Kit (GE Healthcare). The resulting cDNA was then subjected to
PCR analysis using 4 primer pairs: KEAP1-N-fwd, 5’-
CCTGCAGTGACTTCCTGGTG-3’ (forward); KEAP1-N-rvs,
5’-GTGGAAGACCTCGGACTCG-3’ (reverse); KEAP1-C-fwd,
5’-ATGAGCGTGCCCCGTAAC-3’ (forward); KEAP1-C-rvs, 5’-
CACGGCATAAAGGAGACGAT-3’ (reverse); KEAP1-mut-fwd,
5’-CATCTACATGCATTTTGGGGAG-3’ (forward); KEAP1-
mut-rvs, 5’-TAGTCCTTGCAGCGGGAGTT-3’ (reverse); GAP-
DH-fwd, 5’-ACCACAGTCCATGCCATCAC-3’ (forward); GA-
PDF-rvs, 5’-TCCACCACCCTGTTGCTGTA-3’ (reverse). The
KEAP1-mut-rev primer contained the "T" nucleotide at the 3’ end
to achieve specific amplification of mutated allele. The wild type
full-length KEAP1 cDNA and truncated KEAP1 cDNA containing
c.879_880delinsA mutation were cloned into SfiI and XhoI sites of
pCMV-myc plasmid (Life Technologies) for the control templates
of PCR.
Real-time PCR
The cDNA generated as mentioned above was also subjected to
real-time PCR analysis in triplicate for evaluation of the expression
of NFE2L2 and its target genes glutathione S-transferase alpha 4
(GSTA4), glutamate-cysteine ligase catalytic subunit (GCLC) and
NAD(P)H dehydrogenase quinone 1 (NQO1) with the use of a
TaqMan Gene Expression Assay (Life Technologies) and the On
ECO Real-time PCR System (Illumina), with glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) cDNA serving as an endog-
enous control. The following TaqMan probes were used: NFE2L2
(Hs00232352_m1), GSTA4 (Hs00155308_m1), GCLC
(Hs00155249_m1) and NQO1 (Hs00168547_m1). The amount of
mRNA was calculated by the comparative CT method [24], and
all data were normalized by the amount of GAPDH mRNA.
Results
Genome-wide SNP typing enables the estimation of pairwise
identity-by-descent (IBD) to examine the relationships of family
members. Because pedigree error leads to incorrect results for
linkage analysis, we first calculated the pairwise proportions of
IBD in all of the samples and compared them with the theoretical
values obtained from the pedigree chart. The genetic relationship
of all of the pairs was consistent with the clinically obtained family
relationship data (Figure S3); thus, linkage analysis was performed
based on the original pedigree.
The results of the multipoint linkage analyses using SNP
markers are shown in Figure 2. A maximum parametric LOD
(pLOD) score of 2.41 was obtained on chromosome 19, spanning
approximately 25 Mb between rs890862 and rs4805677. The
information scores approached 0.9 as the interval of the markers
became narrower (Figure 2B), suggesting that analysis with a
0.2 cM marker interval was a more powerful test than a 1.0 cM
Figure 2. Summary of the genome-wide SNP linkage analysis. (A) The multipoint parametric LOD (pLOD) score with a marker interval of
1.0 cM is shown for all of the autosomes and the X chromosome. (B) The multipoint pLOD and the information score of chromosome 19 are shown.
The black and red lines (or dot) denote results from 1.0 and 0.2 cM marker interval analysis, respectively.
doi:10.1371/journal.pone.0065141.g002
A KEAP1 Mutation in a Familial Multinodular Goitre
PLOS ONE | www.plosone.org 3 May 2013 | Volume 8 | Issue 5 | e65141
interval. Linkage signals for the previously reported loci, MNG-1,
-2 and -3 and chromosomes 2q, 3p, 7q and 8p, were almost zero
(Figure 2A). The linkage analysis suggested that 19p13.2-q12 is a
causative region in this family.
Three candidate genes were present within this linkage region:
translocase of inner mitochondrial membrane 44 (TIMM44),
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13
(NDUFA13) and solute carrier family 5 (sodium iodide symporter),
member 5 (SLC5A5). Mutations in TIMM44 and NDUFA13 have
been reported to be associated with tumorigenesis in the thyroid
[25,26], and the SLC5A5 gene encodes sodium-iodide symporter
protein, whose down-regulation is associated with thyroid carci-
nomas [27]. However, no mutation was identified in these genes in
our samples (data not shown).
Considering the broad range of the linkage region, in which
approximately 660 genes reside, we applied a next-generation
sequencing technique for the identification of the causative
mutation of MNG. The genomic DNA from a proband was
subjected to exon capture, and a total of 263,794,206 reads with
75 bases were obtained with sequencing. A total of 5,314,723
reads were mapped to the reference sequence of chromosome 19
using CLC Genomics Workbench. The mean depth of coverage for
the coding sequences was 92.1x, and 88.9% of the coding
sequences on chromosome 19 were covered at greater than or
equal to 1x depth. Within the exons and exon-intron boundaries of
the linkage region, 7,222 single-nucleotide variations and 419
small deletions/insertions were detected with the SNP and DIP
detection algorithms, respectively. After removing known variants,
synonymous substitutions, systematic artefacts and coverage
,10x, seven variants remained (Table 1 and Figure S2).
The six missense variants and one deletion were evaluated to
determine functionally significant changes using Mutant Taster
(http://www.mutationtaster.org/), PolyPhen-2 (http://genetics.
bwh.harvard.edu/pph2/) and SIFT (http://sift.bii.a-star.edu.sg/)
programs [21–23]. Four variants located in ICAM3, ZNF440,
C19orf44 or ZNF430 were assumed to lead to non-hazardous
changes in protein function because at least two programs
evaluated them as "polymorphism", "benign" or "tolerated"
(Table 1). Indeed, the variants in ICAM3, ZNF440 or C19orf44
were recently identified by 1000 Genome Project (rs117942573,
rs117998813 or rs199764040, respectively). Therefore, we exclud-
ed these four variants from further analysis. A variant in MUC16
was evaluated as "polymorphism" by the Mutation Taster
program, and expression of this gene in the thyroid was suggested
to be considerably low based on several databases including
BioGPS (http://biogps.org/), Cancer Genome Anatomy Project
(http://cgap.nci.nih.gov/SAGE) and GeneHub-GEPIS (http://
research-public.gene.com/Research/genentech/genehub-gepis/).
These results suggested that the variant in MUC16 could not be a
significant candidate of causative mutation of the MNG.
Regarding a variant in FBN3, all of the read contained the
variant base, indicating that the genotype was homozygous for the
variant. Therefore, it was unlikely that this variant causes the
disease with dominant mode of inheritance. Finally, we selected a
frame shift variant in KEAP1 for further analysis because it was a
novel variant, evaluated as "disease causing", and showed
heterozygous genotype.
Direct sequencing of the KEAP1 variant in the proband
identified a frameshift mutation in exon 3 of the gene:
c.879_880delinsA, p.Asp294Thr, fs*23 (Figure 3A). The subse-
quent sequencing of family members confirmed the co-segregation
of the mutation in affected individuals (Figure S4). However, the
mutation was not observed in 192 Japanese normal control
samples.
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KEAP1 is a cytoplasmic protein that acts as a negative regulator
of NFE2L2 [28–30]. KEAP1 interacts with NFE2L2 via an DC
domain comprising six Kelch repeats and a C-terminal region and
also associates with CUL3 via a broad complex tramtrack bric-a-
brac (BTB) homodimerisation domain to form an E3 ubiquitin
ligase complex, resulting in the constitutive degradation of
NFE2L2 (Figure 3B). Somatic mutations that impair the function
of KEAP1 and lead to the constitutive stabilisation of NFE2L2
have been found in lung, gallbladder and liver cancer in humans
(Figure 3B) [31,32]. Because the p.Asp294Thr, fs*23 mutation
identified in this study resides in a DC domain, we questioned
whether this mutation could generate a truncated KEAP1 protein
or not. We examined the expression of the mutant KEAP1 in the
thyroid tissues of the patient by reverse transcriptase-PCR using 3
primer pairs (Fig 4A). We designed a primer pair (KEAP1-mut-
fwd and KEAP1-mut-rvs) that specifically amplifies mutant KEAP1
and 2 primer pairs that amplify 5’ or 3’ portion flanking the
mutation of KEAP1 (KEAP1-N-fwd and KEAP-N-rvs, or KEAP1-
C-fwd and KEAP1-C-rvs, respectively). It was found that
expression of the c.879_880delinsA mutant was almost nil in the
thyroid tissues of the patient as well as in the normal thyroid (Fig
4B, upper panel). On the other hand, expression of the 5’ and 3’
portion of KEAP1 were observed in the thyroid of patient;
however, the expression level was lower in the tissues of patient
than normal thyroid (Fig. 4B, second and third panels). These
results suggested that truncated KEAP1 protein is not generated
probably due to non-sense mediated mRNA decay, and that the
expression of wild type KEAP1 protein might be decreased due to
low transcription product, at least in the thyroid tissues of the
patient.
To investigate the effect of decreased expression of KEAP1, we
performed qPCR analysis for the NFE2L2 target genes, GCLC,
GSTA4 and NQO1. As shown in Figure 5, the expression of GCLC
and GSTA4 were significantly elevated in both the normal and
goitre portion of the thyroid tissue obtained from the proband
compared with control thyroid RNA. Regarding NQO1, an
increasing trend was detected, but this increase was not statistically
significant. The expression of NFE2L2 was not changed, consistent
with the theory that KEAP1 affects NFE2L2 localisation but not
expression. The results suggested that the decreased expression of
KEAP1 might result in activation of NFE2L2 target genes, at least
in the thyroid of the patients.
Discussion
The thyroid gland maintains its homeostasis in the face of an
increased burden of free radicals and reactive oxygen species
produced during iodine metabolism for thyroid hormone synthe-
Figure 3. Identification of a heterozygous mutation in KEAP1. (A) The result of Sanger sequencing of proband DNA showed the
c.879_880delinsA mutation (red), resulting in a 1-base deletion and a frameshift (p.Asp294Thr, fs*23) in KEAP1. (B) Domain structure and mutation
location in the KEAP1 protein. The protein consists of an N-terminal region (NTR; amino acids 1 to 60), a BTB domain (amino acids 61 to 179), an
intervening region (IVR; amino acids 180 to 314) and a DC domain (amino acids 315 to 624). The BTB and N-terminal portion of IVR is responsible for
dimerisation and the interaction with CUL3. The DC domain is also critical for the interaction with NFE2L2. The p.Asp294Thr, fs*23 mutation is located
in the IVR. The reported frequencies of the somatic mutations observed in each domain in cancer cells are shown at the bottom [32].
doi:10.1371/journal.pone.0065141.g003
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sis. When the gland is exposed to additional oxidative stress caused
by smoking and iodine deficiency, it is assumed that the excessive
damage of lipids, proteins and DNA leads to thyroid dysfunction,
including goitre formation. Indeed, these environmental factors
are well known risk factors for MNG. Therefore, the genes
involved in the signal cascades protecting cellular homeostasis
against oxidative stress would be candidates for the genetic
aetiology of MNG.
The KEAP1-NFE2L2 regulatory pathway is a major biological
defence system against oxidative damage [32,33]. In response to
oxidative and electrophilic stress, key cysteine residues of KEAP1
are oxidised to allow NFE2L2 to dissociate from the ubiquitination
activity of the complex. NFE2L2 subsequently translocates into the
nucleus and transactivates a series of cytoprotective genes,
including NQO1, GCLC and GST. Notably, somatic mutations
that stabilise NFE2L2, thus conferring protection against oxidative
stress, have been identified in KEAP1 in human cancers [32]. To
our knowledge, however, germline mutation in KEAP1 has not
been described in familial cancer cases. A recent study suggested
that the NFE2L2-mediated adaptation to oxidative stress is crucial
for the early stages of tumour development [34]. In this study, we
observed that the expression of NFE2L2 target genes were
increased accompanied by decreased expression of wild type
KEAP1 in the thyroid tissues obtained from the proband. This
suggests that the KEAP1-NFE2L2 pathway might be impaired in
the tissues of the patient with the heterozygous c.879_880delinsA
mutation, supporting that this MNG family showed dominant
mode of inheritance.
The mechanisms through which the patients in the present
study were affected with only MNG are unclear. One possibility is
that the thyroid gland is most susceptible to additional oxidative
stress, in other words, dysregulated NFE2L2 activation, because
this gland is physiologically and continuously exposed to stress
during hormone synthesis. It is also possible that tumours
developed in multiple organs but were not clinically detected
due to insufficient examination. An intensive follow-up of the
course of the patients would be required for the early diagnosis of
tumours in different organs.
Several linkage loci in addition to chromosome 19 have been
detected for familial MNG; therefore, it cannot be concluded that
the KEAP1 is the major causative gene of familial cases. Indeed,
this is the first report of KEAP1 mutation in thyroid diseases.
Figure 4. Reverse transcriptase-PCR for mutant and wild type KEAP1. (A) Primer positions for reverse transcriptase-PCR in KEAP1 exons. The
asterisk indicates the position of c.879_880delinsA mutation in exon 3. The primer, KEAP1-mut-rvs, contains "T" nucleotide at the 3’ end which is the
complement of mutant "A" nucleotide to amplify mutant allele. The expected sizes of PCR products are as follows: 233 bp for KEAP1-N-fwd and
KEAP1-N-rvs; 201 bp for KEAP1-C-fwd and KEAP1-C-rvs; 282 bp for KEAP1-mut-fwd and KEAP1-mut-rvs. (B) Results of the reverse transcriptase-PCR for
the mutant and wild type KEAP1. cDNAs from control normal thyroid, the normal and goitre region of thyroid tissues obtained from the proband
were amplified by 3 primer sets indicated in (A) to mutant KEAP1 (upper panel), 5’ and 3’ normal portions adjacent mutation site (second and third
panels, respectively) of KEAP1. GAPDH was amplified as a control for the amount of cDNA in each sample. The expected size of PCR product of GAPDH
is 452 bp. In the experiment of mutant KEAP1 amplification, the plasmids containing mutant or wild type KEAP1 (pCMV-myc-KEAP1mut or pCMV-
myc-KEAP1wt, respectively) were utilized as control templates.
doi:10.1371/journal.pone.0065141.g004
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However, the association of common variants of KEAP1 and
NFE2L2 with sporadic cases of MNG should be considered.
In summary, we identified a new MNG locus on chromosome
19p13.2-q12 through linkage analysis using high-density SNP
markers. Subsequent sequence analysis focused on the linkage
region revealed a heterozygous mutation of c.879_880delinsA,
p.Asp294Thr, fs*23 in KEAP1, which plays a central role in cell
protection against oxidative stress. In agreement with the
molecular function of KEAP1, the NFE2L2 target genes GSTA4
and GCLC were up-regulated in the thyroid tissues of the patient,
which may be caused by low expression of wilt type KEAP1. The
present study implies that a functional defect of genes involved in
maintaining the homeostasis against the oxidative stress physio-
logically generated during thyroid hormone synthesis could cause
tumorigenesis in this organ.
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